Asadullah Khan
Wake Forest University Health Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Asadullah Khan as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:46 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03363659 · Disulfiram and Copper Gluconate With Temozolomide in Unmethylated Glioblastoma MultiformeWake Forest University Health Sciences · terminated · Glioblastoma, Glioblastoma Multiforme · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:46 UTC. The ranking covers the 200 most relevant of 768 PubMed records, and a shared surname and initials can bring in a namesake. All 768 on PubMed
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.N Engl J Med · 20181,612 citationsRCR 74.0
- 1,284 citationsRCR 71.4
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.N Engl J Med · 2018937 citationsRCR 42.8
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.N Engl J Med · 2021788 citationsRCR 47.4
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.N Engl J Med · 2021753 citationsRCR 43.8
- Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.N Engl J Med · 2023749 citationsRCR 61.8
- Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.N Engl J Med · 2019660 citationsRCR 33.2
- Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.N Engl J Med · 2020653 citationsRCR 33.4
- 583 citationsRCR 17.3
- 433 citationsRCR 32.2